Johnson Matthey (LON:JMAT – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Jefferies Financial Group in a report released on Tuesday, Marketbeat Ratings reports. They presently have a GBX 1,800 ($22.63) target price on the stock. Jefferies Financial Group’s target price indicates a potential upside of 33.23% from the stock’s current price.
Separately, Berenberg Bank reduced their target price on Johnson Matthey from GBX 1,650 ($20.74) to GBX 1,500 ($18.86) and set a “hold” rating on the stock in a report on Thursday, November 28th.
Get Our Latest Stock Analysis on JMAT
Johnson Matthey Trading Down 2.0 %
Insiders Place Their Bets
In other news, insider Stephen Oxley bought 24 shares of Johnson Matthey stock in a transaction dated Wednesday, November 20th. The stock was bought at an average cost of GBX 1,504 ($18.91) per share, for a total transaction of £360.96 ($453.81). Also, insider Liam Condon purchased 27 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were purchased at an average cost of GBX 1,505 ($18.92) per share, for a total transaction of £406.35 ($510.88). Over the last three months, insiders acquired 7,458 shares of company stock worth $10,024,332. 0.61% of the stock is owned by corporate insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
- Five stocks we like better than Johnson Matthey
- What is the Nikkei 225 index?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Stock Dividend Cuts Happen Are You Ready?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What Investors Need to Know About Upcoming IPOs
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.